Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (31)
Panoraia I. Siafaka, Emre Şefik Çağlar, Hande Sipahi, Mohammad Charehsaz, Ahmet Aydın & Neslihan Üstündağ Okur. (2021) Ocular microemulsion of brinzolamide: Formulation, physicochemical characterization, and in vitro irritation studies based on EpiOcular™ eye irritation assay. Pharmaceutical Development and Technology 26:7, pages 765-778.
Read now
Read now
Ningli Wang, Da-Wen Lu, Yingzi Pan, Yury Astakhov, Tatyana Iureva, Adeniyi Adewale & Thomas M Walker. (2020) Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension. Clinical Ophthalmology 14, pages 221-230.
Read now
Read now
Anastasios G. Konstas, Leopold Schmetterer, Vital P. Costa, Gábor Holló, Andreas Katsanos, Philippe Denis, Luciano Quaranta, Murat Irkec, Miguel A. Castejón, Miguel A. Teus & Alan L. Robin. (2020) Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review. Expert Opinion on Drug Safety 19:11, pages 1445-1460.
Read now
Read now
Mohammad Mehdi Mahboobian, Ali Seyfoddin, Reza Aboofazeli, Seyed Mohsen Foroutan & Ilva Dana Rupenthal. (2019) Brinzolamide–loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests. Pharmaceutical Development and Technology 24:5, pages 600-606.
Read now
Read now
Vital Paulino Costa, Tin Aung & Anastasios G. Konstas. (2019) Evolution of the treatment paradigm for maximum medical therapy in glaucoma. Expert Review of Ophthalmology 14:1, pages 33-42.
Read now
Read now
Vassilios Kozobolis, Aristeidis Konstantinidis, Haris Sideroudi & Miguel Teus. (2018) Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation. Clinical Ophthalmology 12, pages 2393-2398.
Read now
Read now
Xinghuai Sun, Mingkai Lin, Xuanchu Duan, Chun Zhang & Jian Ming. (2017) Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China. Patient Preference and Adherence 11, pages 845-852.
Read now
Read now
Hideaki Okumichi, Yoshiaki Kiuchi, Tetsuya Baba, Takashi Kanamoto, Tomoko Naito, Shunsuke Nakakura, Hitoshi Tabuchi, Hiroki Nii, Chie Sueoka & Yosuke Sugimoto. (2017) The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study. Clinical Ophthalmology 11, pages 1175-1181.
Read now
Read now
Lutz E Pillunat, Carl Erb, Auli Ropo, Friedemann Kimmich & Norbert Pfeiffer. (2017) Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study. Clinical Ophthalmology 11, pages 1051-1064.
Read now
Read now
Tadashi Nakano, Shiro Mizoue, Nobuo Fuse, Aiko Iwase, Shun Matsumoto & Keiji Yoshikawa. (2017) Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue. Clinical Ophthalmology 11, pages 55-61.
Read now
Read now
Jukka Mäenpää & Olavi Pelkonen. (2016) Cardiac safety of ophthalmic timolol. Expert Opinion on Drug Safety 15:11, pages 1549-1561.
Read now
Read now
Anastasios G. P. Konstas & Gabor Holló. (2016) Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma. Expert Opinion on Pharmacotherapy 17:9, pages 1271-1283.
Read now
Read now
Nuwan Niyadurupola & David C. Broadway. (2016) Special considerations for glaucoma management in the elderly. Expert Review of Ophthalmology 11:3, pages 181-189.
Read now
Read now
Romeo Altafini, Maria-Luise Scherzer, Douglas A Hubatsch & Paolo Frezzotti. (2015) Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study. Clinical Ophthalmology 9, pages 2263-2270.
Read now
Read now
Dietmar Schnober, Douglas A Hubatsch & Maria-Luise Scherzer. (2015) Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy. Clinical Ophthalmology 9, pages 825-832.
Read now
Read now
Kailin Tian, Shannon Shibata-Germanos, Milena Pahlitzsch & M Francesca Cordeiro. (2015) Current perspective of neuroprotection and glaucoma. Clinical Ophthalmology 9, pages 2109-2118.
Read now
Read now
Quang H Nguyen. (2014) Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus. Patient Preference and Adherence 8, pages 853-864.
Read now
Read now
Marcelo Lopes da Silva Jordão, Marcelo Hatanaka, Abayomi Ogundele, Maria Rosa Bet de Moraes Silva & Roberto Murad Vessani. (2014) Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy. Clinical Ophthalmology 8, pages 1527-1534.
Read now
Read now
Purvi Bhagat, Kalyani Sodimalla, Chandrima Paul, Surinder S Pandav, Ganesh V Raman, Rengappa Ramakrishnan, Abhijeet Joshi & Atul Raut. (2014) Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 8, pages 1241-1252.
Read now
Read now
Keiji Yoshikawa, Jun Kozaki & Hidetaka Maeda. (2014) Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 8, pages 389-399.
Read now
Read now
Sky K Chew, Simon E Skalicky & Ivan Goldberg. (2014) Brinzolamide plus brimonidine for the treatment of glaucoma: an update. Expert Opinion on Pharmacotherapy 15:16, pages 2461-2471.
Read now
Read now
Gábor Holló, Fotis Topouzis & Robert D Fechtner. (2014) Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice. Expert Opinion on Pharmacotherapy 15:12, pages 1737-1747.
Read now
Read now
Jess T Whitson, Tony Realini, Quang H Nguyen, Matthew G McMenemy & Stephen M Goode. (2013) Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension. Clinical Ophthalmology 7, pages 1053-1060.
Read now
Read now
Glenis J Crane, Steven M Kymes, Janet E Hiller, Robert Casson & Jonathan D Karnon. (2013) Development and calibration of a constrained resource health outcomes simulation model of hospital-based glaucoma services. Health Systems 2:3, pages 181-197.
Read now
Read now
Leopoldo Martín Baiza-Durán, Juan Francisco Llamas-Moreno & Clotilde Ayala-Barajas. (2012) Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 6, pages 1051-1055.
Read now
Read now
Anastasios GP Konstas, Luciano Quaranta & Tony Realini. (2012) Overview of the BAK-free travoprost/timolol BAK-free fixed combination. Expert Opinion on Pharmacotherapy 13:5, pages 757-766.
Read now
Read now
F. Aptel & P. Denis. (2011) Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin–timolol fixed combinations in primary open-angle glaucoma. Current Medical Research and Opinion 27:10, pages 1949-1958.
Read now
Read now
Anne J Lee & Ivan Goldberg. (2011) Emerging drugs for ocular hypertension. Expert Opinion on Emerging Drugs 16:1, pages 137-161.
Read now
Read now
Anton Hommer. (2011) Role of fixed combinations in the management of open-angle glaucoma. Expert Review of Pharmacoeconomics & Outcomes Research 11:1, pages 91-99.
Read now
Read now
Philippe Denis. (2011) Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review. Expert Opinion on Pharmacotherapy 12:3, pages 463-471.
Read now
Read now
Nicholas P Bell, José L Ramos & Robert M Feldman. (2010) Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension. Clinical Ophthalmology 4, pages 1331-1346.
Read now
Read now